Swedencare AB (publ) Logo

Swedencare AB (publ)

Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.

SECARE | ST

Overview

Corporate Details

ISIN(s):
SE0015988167
LEI:
549300FZT7YIF6SWX789
Country:
Sweden
Address:
C/O Medeon Science Park, 205 12 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Swedencare AB is a global group that develops, produces, and markets premium pet health products, primarily for cats, dogs, and horses. The company's portfolio includes a range of strong brands offering supplements, natural and organic products, and specialty pharmaceuticals. A key component of its growth strategy is the acquisition of established companies to expand its market presence and product offerings. Swedencare utilizes a multi-channel distribution model, selling its products through a global network of veterinary clinics, pet stores, and leading e-commerce platforms like Amazon and Chewy. The company focuses on innovation and aims to outperform market growth by meeting the increasing consumer demand for high-quality pet care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Swedencare AB (publ) filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Swedencare AB (publ)

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Swedencare AB (publ) via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-24 Thomas Eklund Other Buy 12,560 426,412.00 SEK
2025-01-08 Laszlo Janos Varga Other Buy 500 22,550.00 SEK
2025-01-07 Laszlo Janos Varga Other Buy 500 23,420.00 SEK

Peer Companies

BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
Cambrex Logo
United States of America
CBM
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL

Talk to a Data Expert

Have a question? We'll get back to you promptly.